Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-003607-59Phase 4Terminated
A Phase 4 trial of paritaprevir, dasabuvir, ribavirin in chronic hepatitis C (CHC), sponsored by DIPARTIMENTO AD ATTIVITÃ INTEGRATA CHIRURGICO, MEDICO, ODONTOIATRICO E DI SCIENZE MORFOLOGICHE. Started Jun 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-003607-59.